mTORC1 activity negatively regulates human hair follicle growth and pigmentation
EMBO Reports · 05.07.2023 · 24 (7)
DOI: 10.15252/embr.202256574 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO Reports, online erschienen am 22.05.2023. Verfasst von Takahiro Suzuki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dr Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA. Hauptthemen laut MEDLINE: Hair Follicle, Pigmentation. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Frost Endowed Scholarship.
Abstract (Originalsprache)
Dysregulation of the activity of the mechanistic target of rapamycin complex 1 (mTORC1) is commonly linked to aging, cancer, and genetic disorders such as tuberous sclerosis (TS), a rare neurodevelopmental multisystemic disease characterized by benign tumors, seizures, and intellectual disability. Although patches of white hair on the scalp (poliosis) are considered as early signs of TS, the underlying molecular mechanisms and potential involvement of mTORC1 in hair depigmentation remain unclear. Here, we have used healthy, organ‐cultured human scalp hair follicles (HFs) to interrogate the role of mTORC1 in a prototypic human (mini‐)organ. Gray/white HFs exhibit high mTORC1 activity, while mTORC1 inhibition by rapamycin stimulated HF growth and pigmentation, even in gray/white HFs that still contained some surviving melanocytes. Mechanistically, this occurred via increased intrafollicular production of the melanotropic hormone, α‐MSH. In contrast, knockdown of intrafollicular TSC2, a negative regulator of mTORC1, significantly reduced HF pigmentation. Our findings introduce mTORC1 activity as an important negative regulator of human HF growth and pigmentation and suggest that pharmacological mTORC1 inhibition could become a novel strategy in the management of hair loss and depigmentation disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
- Foundation for Hair Restoration, Miami, FL, USA.
- Bauman Medical Group, Boca Raton, FL, USA.
- Max Planck Institute for Biology of Ageing, Cologne, Germany.
- Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
- Monasterium Laboratory, Muenster, Germany.
ORCID-Profile: Takahiro Suzuki, Jérémy Chéret, Jennifer Gherardini, Alan J Bauman, Constantinos Demetriades, Ralf Paus
Förderung
- Frost Endowed Scholarship
Zitieren
APA
Suzuki, T., Chéret, J., Scala, F. D., Akhundlu, A., Gherardini, J., Demetrius, D. L., O'Sullivan, J. D. B., Kuka Epstein, G., Bauman, A. J., Demetriades, C., & Paus, R. (2023). mTORC1 activity negatively regulates human hair follicle growth and pigmentation. EMBO Reports, 24(7). https://doi.org/10.15252/embr.202256574
Vancouver
Suzuki T, Chéret J, Scala FD, Akhundlu A, Gherardini J, Demetrius DL, et al. mTORC1 activity negatively regulates human hair follicle growth and pigmentation. EMBO Reports. 2023;24(7). doi:10.15252/embr.202256574
BibTeX
@article{Suzuki2023,
author = {Suzuki, Takahiro and Chéret, Jérémy and Scala, Fernanda Dinelli and Akhundlu, Aysun and Gherardini, Jennifer and Demetrius, Dana-Lee and O'Sullivan, James D B and Kuka Epstein, Gorana and Bauman, Alan J and Demetriades, Constantinos and Paus, Ralf},
title = {mTORC1 activity negatively regulates human hair follicle growth and pigmentation},
journal = {EMBO Reports},
year = {2023},
volume = {24},
number = {7},
doi = {10.15252/embr.202256574}
}
EUVIMED